Denmark· DK-28106780922
Lytgobi
A futibatinib product containing futibatinib, registered in Denmark by Taiho Pharma Netherlands B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Futibatinib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01EN04 (futibatinib), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Futibatinib · ATC L01EN04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of futibatinib costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.36 in France to $366.73 in Switzerland — a ×1007 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Futibatinib · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$366.73
- FR France$0.36
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Futibatinib
- Manufacturer
- Taiho Pharma Netherlands B.V.
- Country
- Denmark (DK)
- ATC code
- L01EN04
- ATC class
- Futibatinib
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106780922
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01EN04
Futibatinib, as other registers publish it.
- FinlandLytgobiTaiho Pharma Netherlands B.V.
- IcelandLytgobiTaiho Pharma Netherlands B.V.
- PolandLytgobiTaiho Pharma Netherlands B.V.
- CzechiaLYTGOBITaiho Pharma Netherlands B.V., Amsterdam
- CzechiaLYTGOBITaiho Pharma Netherlands B.V., Amsterdam
- United StatesLYTGOBITAIHO PHARMACEUTICAL CO., LTD.
- United StatesLYTGOBITAIHO PHARMACEUTICAL CO., LTD.
- CzechiaLYTGOBITaiho Pharma Netherlands B.V., Amsterdam
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb000c28-fbce-4258-9fc9-74d38ebb96cd GET /v1/drugs/bb000c28-fbce-4258-9fc9-74d38ebb96cd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "4 mg",
"auth_role": "MOD",
"dk_drugid": "28106780922",
"substance": "Futibatinib",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "45111"
}See everything about futibatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.